Direct costs include those associated with the use of healthcare resources, such as inpatient/outpatient care, and drugs.3,5 A UK survey evaluated the costs associated with the use of healthcare services in 432 patients diagnosed with PD.3,4 Overall, the direct costs of PD care increased with advancing age, driven mainly by the worsening severity of symptoms.3,4 As PD progresses, patients may develop co-morbidities, requiring the use of additional healthcare resources, and many patients will eventually enter residential/nursing home care.3,4

Inpatient care is a major component of the direct costs of PD.5 These are mostly emergency admissions, leading to longer hospital stays when compared with age-matched individuals without PD.1

References:
1.Low V, Ben-Shlomo Y, Coward E, et al. Measuring the burden and mortality of hospitalisation in Parkinson’s disease: a cross-sectional analysis of the English Hospital Episodes Statistics database 2009–2013. Parkinsonism Relat Disord 2015; 21 (5): 449–454.

2.Kruse C, Lipinski A, Verheyen M, et al. Care of late-stage Parkinsonism: resource utilization of the disease in five European countries. Mov Disord 2024; 39 (3): 571–584.

3.Findley LJ. The economic impact of Parkinson’s disease. Parkinsonism Relat Disord 2007; 13: S8–S12.

4.Findley L, Aujla M, Bain PG, et al. Direct economic impact of Parkinson’s disease: a research survey in the United Kingdom. Mov Disord 2003; 18 (10): 1139–1145.

5.Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinsons Dis 2020; 6: 15.